5 Monthly Dividend Stocks Paying Up To 18.2%

Monthly dividend stocks are gaining traction for retirement income, offering payouts alongside regular expenses. While some monthly payers yield little, this report identifies five high-yield options averaging 10.6% annually, capable of generating substantial income. Featured are Healthpeak Properties (DOC), a healthcare REIT with improving prospects and a recent joint venture, though its yield is now moderate. Itau Unibanco (ITUB), a Brazilian bank, pays monthly but its primary dividend is annual, limiting consistent income. Gladstone Investment (GAIN), a BDC, offers a solid monthly dividend with potential for supplemental payouts and strong operational performance. PennantPark Floating Rate Capital (PFLT), another BDC, provides floating-rate loans and trades at a significant NAV discount despite a recent dividend adjustment. Lastly, Invesco Mortgage Capital (IVR), an mREIT, boasts an 18% yield, though its dividends have historically been unstable, recently shifting to monthly payments.

Why sit around and wait all quarter long for a dividend payment where there are monthly dividend stocks available? Monthly divvies are where the retirement party is at! These income “cheat codes” arrive alongside our bills and recurring expenses. What a concept! But be careful because some monthly payers don’t pay enough to matter. Take Permian Basin Royalty Trust (PBT) , which pays monthly but these divvies add up to just 1.2% annually. Gee, thanks . We need monthly payers that are committed to maximizing not just the frequency of shareholder rewards, but the size of the payout. And we need to shoot high—we shouldn’t settle for anything less than what it would take to retire on dividends alone . Fortunately for us, many monthly dividend stocks fall within the high-yield acronyms: real estate investment trusts ( REITs ), business development companies ( BDCs ) and the like.

Let’s take a look. Monthly Dividend #1: Healthpeak Properties (DOC) I’ll start with Healthpeak Properties (DOC) , a healthcare REIT whose roughly 690 properties include outpatient medical facilities and laboratories, which are leased out to biopharma firms, health systems, physician groups, medical device manufacturers and more. Healthpeak also deals in senior housing, albeit not as directly as it did just a few months ago. In March, DOC spun off that part of the business with an initial public offering of Janus Living (JAN) . It wasn’t a full exit, however. Healthpeak not only retained more than 80% of the newly formed REIT, but it also is Janus’s external manager. A couple months later, DOC received a much-needed jolt after reporting better-than-expected earnings and upgrading its funds from operations (FFO) outlook. Among the reasons for management’s optimism: The senior housing environment is improving, Janus appears primed to aggressively invest, and a weak laboratories market showed small signs that it’s starting to inflect. And just this week, Healthpeak announced a $2.1 billion joint venture with Brookfield Asset Management (BAM) that will help DOC to pay down nearer-term debt (though it could be a short-term weight on earnings, too). Healthpeak’s stock has delivered a year-to-date total return of almost 45% thanks to its summer ramp...